权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

In vivo modelling of human microglial alterations associated with Alzheimer's disease polygenic risk

与阿尔茨海默病多基因风险相关的人类小胶质细胞改变的体内模型

基本信息

批准号：
1943708
负责人：
金额：
--
依托单位：
CARDIFF UNIVERSITY
依托单位国家：
英国
项目类别：
Studentship
财政年份：
2017
资助国家：
英国
起止时间：
2017 至无数据
项目状态：
已结题

来源：
https://gtr.ukri.org/projects?ref=studentship-1943708
关键词：
vivo modelling human microglial alterations

项目摘要

Genome wide association studies have identified multiple genetic variants that are associated with increased risk of developing Alzheimer's disease (AD). Strikingly, bio-statistical analysis of risk loci most strongly implicates innate immunity and microglia function as target pathways involved in AD etiology. Moreover, novel statistical approaches allow polygenic risk scores for AD to be assigned, with a predictive accuracy for individuals at highest and lowest risk of over 90%. To understand the impact of polygenic risk genotype on mechanisms of AD onset and progression this project will establish novel microglial models from induced pluripotent stem cells (IPSC) derived from individuals in patient cohorts identified at the extremes of polygenic risk of AD. IPSCs will be differentiated into microglia. High and low AD risk IPSCmicroglia will be compared using multiple functional assays e.g. pro- and anti-inflammatory responses to beta-amyloid and cell stress stimuli, cell migration and phagocytosis. Assays will focus on high-content live cell imaging and be developed with a view to rapid translation of work for drug screening and testing with industrial partners. To investigate microglial behavior in vivo and the homeostatic role played in brains of wildtype and transgenic AD model mice, microglial cell transplantation will be used to establish novel human <-> mouse chimeric models. T

全基因组关联研究已经确定了与阿尔茨海默病（AD）风险增加相关的多种遗传变异。引人注目的是，风险基因座的生物统计学分析最强烈地暗示先天免疫和小胶质细胞功能作为参与AD病因学的靶途径。此外，新的统计方法允许分配AD的多基因风险评分，对最高和最低风险个体的预测准确度超过90%。为了了解多基因风险基因型对AD发病和进展机制的影响，该项目将建立新的小胶质细胞模型，该模型来自诱导多能干细胞（IPSC），这些干细胞来源于AD多基因风险极端的患者队列中的个体。IPSC将分化为小胶质细胞。将使用多种功能测定，例如对β-淀粉样蛋白和细胞应激刺激的促炎和抗炎反应、细胞迁移和吞噬作用，比较高和低AD风险IPSC小胶质细胞。检测将侧重于高含量的活细胞成像，并将与工业合作伙伴一起开发，以快速转化药物筛选和测试工作。为了研究小胶质细胞在体内的行为以及在野生型和转基因AD模型小鼠的脑中发挥的稳态作用，小胶质细胞移植将用于建立新的人<->小鼠嵌合模型。不